TB immune response discovery could significantly reduce disease harm

A pioneering study has discovered the presence of a harmful inflammatory protein in patients with symptomatic tuberculosis (TB). Researchers say, by targeting the IL-17 cytokine, a component produced naturally by the immune system in response to infection, excessive and damaging lung inflammation caused by TB may be significantly reduced to help speed up patient recovery.

source https://www.sciencedaily.com/releases/2021/05/210510104329.htm